Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients
Journal of Separation Science · 2026
DOI: 10.1002/jssc.70512 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Separation Science, 2026. Verfasst von Kelly Blundin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Small Molecule Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey, USA. Hauptthemen laut MEDLINE: Nitrites, Excipients. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Laboratories of Merck & Co., Inc., Rahway, NJ, USA, Merck & Co., Inc., Rahway, NJ, USA Future Talent Program.
Abstract (Originalsprache)
Nitrite impurities are frequently present in pharmaceutical excipients as a result of raw material sources and manufacturing processes. These impurities are of regulatory concern because nitrite can react with secondary amines to form nitrosamines, a class of potentially mutagenic compounds, making effective control of nitrite critical to ensuring the safety of pharmaceutical products. Current industrial methods for nitrite detection and quantification, such as ion chromatography and related techniques, are often limited by aqueous solvent compatibility, matrix dependence, or restricted instrument availability, which can hinder routine implementation across diverse pharmaceutical materials. In this study, a fast and sensitive analytical approach was developed to address these limitations by enabling nitrite quantification across excipients spanning a broad range of hydrophilicity to hydrophobicity. The method employs a newly developed nitrite isolation strategy from solid pharmaceutical excipient matrices, followed by rapid derivatization to form a UV‐active species that can be selectively quantified using high‐performance liquid chromatography with ultraviolet detection (HPLC‐UV). The resulting workflow demonstrates robust performance for low‐level nitrite detection while maintaining compatibility with standard HPLC instrumentation across the diverse ranges of tested pharmaceutical ingredients. The widespread availability of HPLC systems, combined with the method's rapid response, selectivity, and low detection limits for nitrite, supports its adoption for routine analytical control. This approach, therefore, provides a practical tool for nitrite monitoring and mitigation of nitrosamine formation risk in pharmaceutical formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Small Molecule Analytical Research and Development, Merck & Co. Inc., Rahway, New Jersey, USA.
- Technical Development, Moderna Inc., Norwood, Massachusetts, USA.
ORCID-Profile: Kelly Blundin, Syamantak Roy, Junyong Jo
Förderung
- Research Laboratories of Merck & Co., Inc., Rahway, NJ, USA
- Merck & Co., Inc., Rahway, NJ, USA Future Talent Program
Zitieren
APA
Blundin, K., Roy, S., Mularz, E., & Jo, J. (2026). Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients. Journal of Separation Science. https://doi.org/10.1002/jssc.70512
Vancouver
Blundin K, Roy S, Mularz E, Jo J. Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients. Journal of Separation Science. 2026. doi:10.1002/jssc.70512
BibTeX
@article{Blundin2026,
author = {Blundin, Kelly and Roy, Syamantak and Mularz, Edward and Jo, Junyong},
title = {Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients},
journal = {Journal of Separation Science},
year = {2026},
doi = {10.1002/jssc.70512}
}
EUVIMED